PTEN activation sensitizes breast cancer to PI3-kinase inhibitor through the β-catenin signaling pathway

Author:            

Publisher: Spandidos Publications

ISSN: 1021-335X

Source: Oncology Reports, Vol.28, Iss.3, 2012-01, pp. : 943-948

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract